Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.45 EUR | -1.02% |
|
+4.60% | +55.20% |
07-10 | AlphaValue/Baader Europe Revises Umicore Rating, EPS Forecasts on Upgraded FY25 Guidance | MT |
07-09 | UMICORE : Well positioned for a cleaner future | ![]() |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.41 | 6.56 | 5.53 | 4.03 | -1.98 | |||||
Return on Total Capital | 5.57 | 11 | 9.35 | 6.49 | -3.26 | |||||
Return On Equity % | 5.15 | 21.66 | 17 | 10.38 | -54.49 | |||||
Return on Common Equity | 5.07 | 21.83 | 17.19 | 10.73 | -52.86 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 5.31 | 6.52 | 6.55 | 8.32 | 8.26 | |||||
EBITDA Margin % | 3.12 | 4.8 | 4.28 | 4.93 | -0.43 | |||||
EBITA Margin % | 2.09 | 3.85 | 3.34 | 3.55 | -2.01 | |||||
EBIT Margin % | 2.03 | 3.79 | 3.3 | 3.51 | -2.07 | |||||
Income From Continuing Operations Margin % | 0.66 | 2.61 | 2.25 | 2.06 | -10.3 | |||||
Net Income Margin % | 0.63 | 2.57 | 2.24 | 2.11 | -9.95 | |||||
Net Avail. For Common Margin % | 0.63 | 2.57 | 2.24 | 2.11 | -9.95 | |||||
Normalized Net Income Margin | 0.84 | 2.15 | 1.77 | 1.88 | -1.61 | |||||
Levered Free Cash Flow Margin | 0.52 | 2.09 | 0.35 | 1.22 | 3.41 | |||||
Unlevered Free Cash Flow Margin | 0.7 | 2.26 | 0.55 | 1.6 | 3.89 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 2.7 | 2.77 | 2.68 | 1.84 | 1.53 | |||||
Fixed Assets Turnover | 9.73 | 10.66 | 10.42 | 6.56 | 5.48 | |||||
Receivables Turnover (Average Receivables) | 16.61 | 17.69 | 19.05 | 16.14 | 17.08 | |||||
Inventory Turnover (Average Inventory) | 7.57 | 8.05 | 7.59 | 5.37 | 5.35 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.62 | 1.71 | 1.58 | 1.62 | 1.29 | |||||
Quick Ratio | 0.77 | 0.82 | 0.71 | 0.78 | 0.73 | |||||
Operating Cash Flow to Current Liabilities | 0.16 | 0.36 | 0.15 | 0.29 | 0.2 | |||||
Days Sales Outstanding (Average Receivables) | 22.03 | 20.64 | 19.16 | 22.62 | 21.43 | |||||
Days Outstanding Inventory (Average Inventory) | 48.33 | 45.33 | 48.06 | 67.99 | 68.45 | |||||
Average Days Payable Outstanding | 30.96 | 32.98 | 33.39 | 45.28 | 48.04 | |||||
Cash Conversion Cycle (Average Days) | 39.4 | 32.99 | 33.84 | 45.33 | 41.84 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 92.47 | 68.04 | 65.72 | 74.33 | 178.83 | |||||
Total Debt / Total Capital | 48.04 | 40.49 | 39.66 | 42.64 | 64.14 | |||||
LT Debt/Equity | 65.04 | 54.43 | 45.6 | 54.62 | 120.57 | |||||
Long-Term Debt / Total Capital | 33.79 | 32.39 | 27.52 | 31.33 | 43.24 | |||||
Total Liabilities / Total Assets | 68.57 | 64.98 | 64.13 | 62.9 | 79.58 | |||||
EBIT / Interest Expense | 6.81 | 14.16 | 10.32 | 5.82 | -2.69 | |||||
EBITDA / Interest Expense | 10.81 | 18.22 | 13.62 | 8.35 | -0.37 | |||||
(EBITDA - Capex) / Interest Expense | 4.46 | 12.33 | 7.98 | 1.03 | -4.97 | |||||
Total Debt / EBITDA | 3.64 | 1.83 | 2.11 | 2.99 | -81.47 | |||||
Net Debt / EBITDA | 2.12 | 0.82 | 1 | 1.34 | -33.76 | |||||
Total Debt / (EBITDA - Capex) | 8.81 | 2.71 | 3.61 | 24.31 | -6.05 | |||||
Net Debt / (EBITDA - Capex) | 5.14 | 1.21 | 1.7 | 10.91 | -2.51 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 18.42 | 16.17 | 5.75 | -28.17 | -18.67 | |||||
Gross Profit, 1 Yr. Growth % | 1.91 | 42.88 | 6.32 | -8.83 | -19.24 | |||||
EBITDA, 1 Yr. Growth % | -1.27 | 86.45 | -5.32 | -17.12 | -106.08 | |||||
EBITA, 1 Yr. Growth % | -6.4 | 127.68 | -7.74 | -23.56 | -137.45 | |||||
EBIT, 1 Yr. Growth % | -6.32 | 132.48 | -7.45 | -23.51 | -138.91 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -54.57 | 361.24 | -8.7 | -34.12 | -506.01 | |||||
Net Income, 1 Yr. Growth % | -54.64 | 374.19 | -7.93 | -32.43 | -484.31 | |||||
Normalized Net Income, 1 Yr. Growth % | -24.21 | 230.04 | -12.19 | -23.56 | -154.8 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -54.62 | 374.07 | -7.42 | -32.49 | -484.64 | |||||
Accounts Receivable, 1 Yr. Growth % | 17.02 | 2.34 | -5.85 | -25.22 | -20.42 | |||||
Inventory, 1 Yr. Growth % | 10.39 | 5.55 | 18.28 | -16.02 | -21 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.29 | 8.66 | 7.71 | 19.92 | -21.28 | |||||
Total Assets, 1 Yr. Growth % | 18.76 | 8.44 | 9.92 | 0.23 | -5.56 | |||||
Tangible Book Value, 1 Yr. Growth % | -1.21 | 24.91 | 14.27 | 3.24 | -52.56 | |||||
Common Equity, 1 Yr. Growth % | -1.4 | 21.73 | 12.97 | 4.11 | -47.07 | |||||
Cash From Operations, 1 Yr. Growth % | 10.25 | 138.22 | -49.61 | 64.41 | -16.68 | |||||
Capital Expenditures, 1 Yr. Growth % | -26.07 | -3.04 | 20.89 | 75.97 | -34.85 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -169.74 | 457.27 | -82.31 | 154.76 | 60.16 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -216.32 | 321.94 | -74.22 | 110.86 | 50.08 | |||||
Dividend Per Share, 1 Yr. Growth % | 100 | 6.67 | 0 | 0 | -37.5 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 22.85 | 17.29 | 10.84 | -12.84 | -23.57 | |||||
Gross Profit, 2 Yr. CAGR % | -1.93 | 20.61 | 23.2 | -1.55 | -14.19 | |||||
EBITDA, 2 Yr. CAGR % | -3.47 | 32.79 | 32.57 | -11.49 | -75.77 | |||||
EBITA, 2 Yr. CAGR % | -8.99 | 41.33 | 44.54 | -16.11 | -40.65 | |||||
EBIT, 2 Yr. CAGR % | -9 | 42.72 | 46.28 | -15.95 | -39.42 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -35.61 | 44.75 | 105.21 | -22.44 | 63.55 | |||||
Net Income, 2 Yr. CAGR % | -35.83 | 46.65 | 108.95 | -21.12 | 61.15 | |||||
Normalized Net Income, 2 Yr. CAGR % | -19.94 | 50.22 | 69.72 | -18.17 | -27.02 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -35.8 | 46.67 | 109.5 | -20.94 | 61.14 | |||||
Accounts Receivable, 2 Yr. CAGR % | 24.23 | 9.43 | -1.84 | -16.09 | -22.86 | |||||
Inventory, 2 Yr. CAGR % | 8.52 | 7.94 | 11.74 | -0.33 | -18.54 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 16.22 | 5.94 | 8.18 | 13.65 | -2.84 | |||||
Total Assets, 2 Yr. CAGR % | 17.38 | 13.48 | 9.18 | 4.96 | -2.71 | |||||
Tangible Book Value, 2 Yr. CAGR % | -1.53 | 11.09 | 19.48 | 8.62 | -30.02 | |||||
Common Equity, 2 Yr. CAGR % | -1.01 | 9.56 | 17.27 | 8.45 | -25.76 | |||||
Cash From Operations, 2 Yr. CAGR % | 339.92 | 62.07 | 9.56 | -8.98 | 17.04 | |||||
Capital Expenditures, 2 Yr. CAGR % | -8.34 | -15.33 | 8.26 | 45.85 | 7.08 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -53.39 | 80.87 | -1.02 | -33.29 | 140.66 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -44.27 | 108.24 | 3.99 | -26.57 | 104.41 | |||||
Dividend Per Share, 2 Yr. CAGR % | 0 | 46.06 | 3.28 | 0 | -20.94 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 20.11 | 20.58 | 13.31 | -4.08 | -14.83 | |||||
Gross Profit, 3 Yr. CAGR % | 5.68 | 11.14 | 15.61 | 11.44 | -7.84 | |||||
EBITDA, 3 Yr. CAGR % | 9.28 | 18.51 | 18.46 | 13.3 | -61.85 | |||||
EBITA, 3 Yr. CAGR % | 8.39 | 20.91 | 22.38 | 16.81 | -31.3 | |||||
EBIT, 3 Yr. CAGR % | 8.77 | 21.65 | 23.3 | 17.77 | -30.27 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -15.98 | 24.12 | 24.14 | 40.51 | 34.66 | |||||
Net Income, 3 Yr. CAGR % | -14.92 | 24.99 | 25.57 | 43.42 | 33.72 | |||||
Normalized Net Income, 3 Yr. CAGR % | -2.02 | 24.04 | 25.35 | 29.99 | -22.44 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -17.74 | 25.02 | 25.82 | 43.63 | 33.96 | |||||
Accounts Receivable, 3 Yr. CAGR % | 7.98 | 16.46 | 4.08 | -10.35 | -17.56 | |||||
Inventory, 3 Yr. CAGR % | 18.62 | 7.52 | 11.29 | 1.59 | -7.76 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 18.47 | 13.64 | 6.53 | 11.96 | 0.55 | |||||
Total Assets, 3 Yr. CAGR % | 17.7 | 14.33 | 12.28 | 6.11 | 1.33 | |||||
Tangible Book Value, 3 Yr. CAGR % | 14.02 | 6.59 | 12.14 | 13.8 | -17.59 | |||||
Common Equity, 3 Yr. CAGR % | 12.35 | 6.06 | 10.68 | 12.71 | -14.61 | |||||
Cash From Operations, 3 Yr. CAGR % | 51.04 | 258.57 | 9.79 | 25.43 | -11.62 | |||||
Capital Expenditures, 3 Yr. CAGR % | 3.7 | -6.61 | -4.66 | 27.29 | 11.5 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -28.41 | 0.63 | -16.84 | 35.07 | 0.39 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -19.33 | 5 | 3.58 | 31.27 | 2.23 | |||||
Dividend Per Share, 3 Yr. CAGR % | 2.33 | 2.17 | 28.73 | 2.17 | -14.5 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 16.39 | 18.17 | 16.31 | 5.9 | -3.2 | |||||
Gross Profit, 5 Yr. CAGR % | 8.22 | 15.4 | 12.34 | 5.86 | 2.61 | |||||
EBITDA, 5 Yr. CAGR % | 10.72 | 21.78 | 17.05 | 5.36 | -37.23 | |||||
EBITA, 5 Yr. CAGR % | 11.9 | 26.52 | 20.05 | 4.35 | -8.42 | |||||
EBIT, 5 Yr. CAGR % | 11.55 | 26.95 | 20.83 | 4.81 | -7.24 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -3.3 | 26.75 | 20.09 | 2.84 | 38.61 | |||||
Net Income, 5 Yr. CAGR % | -5.06 | 36.48 | 21.87 | 3.97 | 38.75 | |||||
Normalized Net Income, 5 Yr. CAGR % | 5.22 | 26.17 | 19.57 | 4.9 | 0.91 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -5.18 | 25.42 | 19.56 | 4.08 | 38.91 | |||||
Accounts Receivable, 5 Yr. CAGR % | 14.16 | 14.56 | 3.94 | 2.15 | -7.67 | |||||
Inventory, 5 Yr. CAGR % | 20.87 | 19.27 | 15.82 | 4.31 | -1.77 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 16.17 | 17.04 | 14.24 | 13.65 | 2.68 | |||||
Total Assets, 5 Yr. CAGR % | 15.66 | 16.89 | 14.21 | 10.48 | 6.03 | |||||
Tangible Book Value, 5 Yr. CAGR % | 8.13 | 12.94 | 16.17 | 7.4 | -7.14 | |||||
Common Equity, 5 Yr. CAGR % | 8.1 | 11.71 | 14.29 | 7.01 | -5.66 | |||||
Cash From Operations, 5 Yr. CAGR % | 14.78 | 26.75 | 32.84 | 107.2 | 12.64 | |||||
Capital Expenditures, 5 Yr. CAGR % | 13.87 | 12.89 | 5.5 | 11.62 | -0.13 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 37.46 | 54.95 | -21.27 | -14.74 | 26.89 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 54.5 | 54.1 | -12.89 | -9.1 | 35.73 | |||||
Dividend Per Share, 5 Yr. CAGR % | 4.56 | 4.24 | 2.71 | 1.3 | 5.92 |
- Stock Market
- Equities
- UMI Stock
- Financials Umicore
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition